Max Harlacher

SonoVol (United States)

Papers

1

Total Citations

18

H-Index

1

About

Max Harlacher is a biomedical engineer whose research centers on preclinical ultrasound imaging, with a particular focus on developing noninvasive in vivo imaging technologies for small animal models. His most cited work, "A new preclinical ultrasound platform for widefield 3D imaging of rodents" (2018, 18 citations), introduces a novel imaging system that enables researchers to capture high-resolution, three-dimensional anatomical and functional data from rodents without the need for invasive procedures. This platform represents a significant contribution to the field by allowing longitudinal studies of disease progression and therapeutic responses in near real-time, bridging a critical gap between preclinical research and clinical translation. Harlacher’s work is notable for its emphasis on widefield imaging, which enhances the ability to detect subtle pathological changes across entire organ systems. Though his citation count is still growing, his innovations have already been recognized for their potential to accelerate drug development and basic biomedical discovery, making him a promising figure in the advancement of noninvasive imaging methodologies.

Research Focus

Key Achievements

1
H-Index
1
Papers
18
Total Citations
18
Avg Citations/Paper
🏆 Most Cited Paper
A new preclinical ultrasound platform for widefield 3D imaging of rodents
18 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: SonoVol (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago